• Latest Posts

Seven pharma companies form alliance to prepare for future pandemics 

Can this Positive Phase III Immunotherapy End Spinal Fractures due to Osteoporosis?

TTP spinout Cellular Origins to focus on cell and gene therapies

Positive results from BioAge muscle atrophy trial 

Deal worth $3.7B sealed as Amgen buys biopharma ChemoCentryx

Biocartis and Amgen Shake Hands on Another Cancer Diagnostics Deal


Amgen Joins €50M German Fundraising for T-Cell Receptor Cancer Immunotherapy

More News! 9 May 2017

Scottish Shark Antibodies have caught Amgen’s Eye

Novartis Negotiates its Way into the US Migraine Market

Interview 17 Apr 2017

Meet One of the Most Successful German Biotech Leaders Ever

German Immuno-Oncology Biotech partners up with Biotech Giant Amgen

€36M Fundraising to Sequence the Genome of Ireland